Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D

Recombinant adenovirus serotype 5 (rAd5) vector-based vaccines are currently being developed for both human immunodeficiency virus type 1 and other pathogens. The potential limitations associated with rAd5 vectors, however, have led to the construction of novel rAd vectors derived from rare Ad serot...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Abbink, Peter, Lemckert, Angelique A. C., Ewald, Bonnie A., Lynch, Diana M., Denholtz, Matthew, Smits, Shirley, Holterman, Lennart, Damen, Irma, Vogels, Ronald, Thorner, Anna R., O'Brien, Kara L., Carville, Angela, Mansfield, Keith G., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology 2007
Hasła przedmiotowe:
Vaccines and Antiviral Agents
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1900173/
https://ncbi.nlm.nih.gov/pubmed/17329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02696-06
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy